PRE CLINICAL TRIAL

  • Bioimmunate has successfully completed POC of removing specific MS related White Blood Cells from patients’ blood.

  • Trail main research was to validate a removal of specific MS related White Blood cells with expression, purification & anchoring of target Proteins to a biocompatible surface.

  • During the research the technology has been tested on blood samples collected from MS patients and proof average removal of target cells of very high rate.

  • Pre-clinical safety trials on rats proof of safe procedure (no mortality, weight loss or changes in blood tests parameters)